The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

Imamura, K; Izumi, Y; Watanabe, A; Tsukita, K; Woltjen, K; Yamamoto, T; Hotta, A; ... Inoue, H; + view all Imamura, K; Izumi, Y; Watanabe, A; Tsukita, K; Woltjen, K; Yamamoto, T; Hotta, A; Kondo, T; Kitaoka, S; Ohta, A; Tanaka, A; Watanabe, D; Morita, M; Takuma, H; Tamaoka, A; Kunath, T; Wray, S; Furuya, H; Era, T; Makioka, K; Okamoto, K; Fujisawa, T; Nishitoh, H; Homma, K; Ichijo, H; Julien, J-P; Obata, N; Hosokawa, M; Akiyama, H; Kaneko, S; Ayaki, T; Ito, H; Kaji, R; Takahashi, R; Yamanaka, S; Inoue, H; - view fewer (2017) The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Science Translational Medicine , 9 (391) , Article eaaf 3962. 10.1126/scitranslmed.aaf3962 . Green open access

https://ift.tt/2DZJ35l